查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190727

電外科發電機市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Electrosurgical Generators Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內，電外科發生器市場的複合年增長率為 6.9%。

雖然 COVID-19 不是一種外科疾病，但它對外科手術產生了相當大的影響。 手術羽流是產生熱組織損傷的能量裝置（包括電外科發電機）的產物。 病毒的結構和穩定性、手術室工作人員可能接觸的劑量以及電外科設備產生煙霧的溫度是影響手術煙霧中發現的病毒顆粒傳染性的一些因素。 此類事件在疫情爆發時嚴重限制了電外科發電機在手術中的使用。

然而，電外科等微創手術 (MIS) 下引入的新安全指南將在 2021 年和 2022 年生效，並對市場增長產生積極影響。. 根據 2022 年 3 月發表在《外科內窺鏡雜誌》(Journal of Surgical Endoscopy) 上的一份報告，採取了預防措施，以避免在每次剖腹手術期間將手術室工作人員暴露於潛在的病毒性手術羽流中。 因此，電外科手術期間的手術羽流安全措施幫助醫生和患者在進行手術時盡量減少接觸 COVID-19。 這些因素有助於市場在大流行後階段的增長。 此外，根據分析，該市場很可能在未來兩到三年內實現大流行前的增長。

此外，由於慢性病和老年人口的增加、對微創手術的需求增加以及電外科發電機的技術進步，電外科發電機市場有望增長。 例如，根據英國心臟基金會的 2022 年報告，英國約有 760 萬人患有心臟和循環系統問題。 此外，由於人口老齡化和不斷增長，以及影響心臟和循環系統的潛在疾病，這一數字可能會繼續上升。 電外科發電機在心臟手術中發揮著重要作用，有助於切割組織和控制出血。 因此，心臟相關疾病負擔的增加將在未來幾年推動醫療環境中對電外科發電機的需求。

此外，關於電外科設備的新研究揭示了設備的安全性，有助於擴大市場。 例如，根據 Cristina Ibanez Jimenez 於 2022 年 2 月發布的一份研究報告，SynchroSeal 的 E-100 電外科發生器的多功能設計提供了增強的密封和切割能力，並具有可接受的安全性。 因此，新的研究將通過提供高效和安全的產品為市場做出貢獻，並將在預測期內推動市場。 然而，與電外科相關的風險和嚴格的監管框架是阻礙市場增長的主要因素。

主要市場趨勢

泌尿外科領域有望佔據大部分市場份額

電外科手術是一種使用電流來切割、移除或破壞組織並控制出血的手術。 它常用於各種泌尿外科手術，例如腎部分切除術、腎盂成形術、腎上腺切除術、根治性前列腺切除術和膀胱切除術。 由於電外科發電機的使用越來越多，預計泌尿外科市場將獲得很大份額。

此外，癌症患者的增加也促進了這一領域的發展。 例如，美國癌症協會 2022 年 1 月發布的一份報告發現，美國男性膀胱癌新發病例為 61,700 例，女性為 19,480 例，估計有 81,180 例膀胱癌新發病例。 這表明這種疾病負擔的嚴重性，增加了對腫瘤切除術的需求。 膀胱切除術是通過手術切除膀胱以治療膀胱癌。

同樣，根據上述消息來源，前列腺癌是美國男性中最常見的癌症之一。 據估計，2022 年將登記 268,490 例前列腺癌新病例。 因此，預計使用電外科發電機進行膀胱切除術和前列腺切除術的需求將增加，最終推動泌尿外科領域對發電機的市場需求。

此外，2021 年 9 月，奧林巴斯推出了其新型 POWERSEAL 系列先進雙極手術能量產品中的第一款設備。 POWERSEAL 設備可用於多種形式的外科手術，包括泌尿外科手術。 因此，由於新產品的批准和推出，預計在預測期內對電外科發電機的需求將出現顯著增長。

預計在預測期內北美將主導市場

由於擁有先進的醫療設施和先進的技術方法，預計北美電外科發生器市場將由美國主導。 預計技術進步將推動市場增長以及癌症等慢性病負擔增加和老年人口增加等主要因素。

例如，加拿大癌症協會估計，到 2022 年底，加拿大將有 233,900 人被診斷出患有癌症，高於 2021 年的 229,200 人。 癌症患者的增加需要腫瘤切除術，這可以通過電外科手術來完成，預計這將在預測期內推動市場。

此外，根據 2022 BC 衛生局的數據，加拿大 90% 的皮膚腫瘤切除病例的手術等待時間估計為 15.2 週。 較長的開放手術等待時間將增加對電外科等微創手術的需求，從而推動醫療機構對電外科發電機的需求。

此外，主要市場參與者的新產品批准和推出正在推動市場增長。 例如，2022 年 1 月，Ethicon 的 Megadyne Electrosurgical Generator 獲得了美國 FDA 的批准。 它旨在用作各種開放式和腹腔鏡手術的通用電外科發生器。 因此，該地區對電外科發電機的新批准將反過來擴大該設備的多種應用範圍，並幫助市場在研究期間增長。

競爭格局

電外科發生器市場較為分散。 世界領先的公司製造了大部分電外科發電機。 擁有更多研究資源和更好分銷網絡的市場領導者已在行業中為自己開闢了一席之地。 主要參與者包括 Medtronic、ConMed Corporation、Johnson & Johnson Services (Ethicon, Inc)、Olympus Corporation、B. Brown SE、Aspen Surgical (Simmarie Surgical Inc)、Medrange, Inc. 和 Applied Medical Resources, Inc.、KARL STORZ SE & Co。 KG, BD (Becton Dickinson & Company)，美國醫療創新公司。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查先決條件和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 慢性病和日益老齡化的人口
    • 對微創手術的需求增加
    • 電外科發電機的技術進步
  • 市場製約因素
    • 與電外科相關的風險
    • 嚴格的監管框架
  • 行業吸引力 - 波特五力分析
    • 新進入者的威脅
    • 買家的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按類型
    • 單極
    • 雙相
    • 兩者
  • 通過申請
    • 普通外科
    • 泌尿科
    • 神經病學
    • 婦科
    • 胃腸病學
    • 其他用途（心髒病學、整形外科、皮膚科）
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶（診所、創傷中心等）
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Medtronic
    • CONMED Corporation
    • Johnson & Johnson Services, Inc.（Ethicon, Inc.）
    • Olympus Corporation
    • B. Braun SE
    • Aspen Surgical（Symmetry Surgical Inc.）
    • Medrange Corporation
    • Applied Medical Resources Corporation
    • KARL STORZ SE & Co. KG
    • BD（Becton, Dickinson and Company）
    • US Medical Innovations

第7章 市場機會今後動向

簡介目錄
Product Code: 93045

The electrosurgical generators market is expected to register a CAGR of 6.9% over the forecast period.

Although COVID-19 was not a surgical disease, it considerably impacted surgical practice. A surgical plume is a by-product of energy devices, including electrosurgical instruments, that creates thermal tissue damage. The structure and stability of the virus, the possible dose to which operating room staff exposed it, and the temperature at which the electrosurgical device produced the smoke were a few factors that affected the infectiousness of viral particles discovered in the surgical plume. Such instances significantly restricted the use of electrosurgical generators in surgical operations amid the outbreak.

However, the introduction of newer guidelines for safety under minimally invasive surgery (MIS), like electrosurgical procedures, was undertaken in the years 2021 and 2022, impacting the market's growth positively. As per the report published by the Journal of Surgical Endoscopy in March 2022, for every open procedure, precautions were taken to keep the operating room staff from being exposed to the surgical plume, which may include viruses. Hence, the safety precautions for surgical plumes during electrosurgical procedures helped physicians and patients perform the surgery with minimal exposure to COVID-19. Such factors have contributed to the market's growth in the post-pandemic phase. Furthermore, as per the analysis, the market is likely to achieve its pre-pandemic growth in the next two to three years.

In addition, the electrosurgical generator market is expected to grow due to the rise in chronic diseases and the geriatric population, increasing demands for minimally invasive surgeries, and technological advancements in electrosurgical units. For instance, according to the British Heart Foundation's 2022 report, approximately 7.6 million people in United Kingdom have heart and circulatory disorders. Moreover, with an aging and growing population, as well as underlying conditions affecting the heart and circulatory system, these numbers could keep rising. Electrosurgical generators play a vital role in cardiac surgeries, helping to cut the tissues and control bleeding. Thus, the increasing burden of heart-related disorders will, in turn, boost the demand for electrosurgical generators in healthcare settings over the coming years.

Furthermore, the new research studies on electrosurgical devices reveal the safety profile of the devices and help in the market's growth. For instance, as per the study report by Cristina Ibanez Jimenez in February 2022, SynchroSeal's multifunctional design with the E-100 electrosurgical generator provides enhanced sealing and transection capabilities with an acceptable safety profile. Thus, the new studies help the market by providing efficient and safe products and will drive the market over the forecast period. However, the risks associated with electrosurgical procedures and stringent regulatory frameworks are the major factors hindering market growth.

Key Market Trends

Urology Segment Expected to Hold Major Market Shares

Electrosurgery is a procedure that uses an electric current to cut, remove, or destroy tissue and control bleeding. It is commonly used in various urologic surgeries, such as partial nephrectomy, pyeloplasty, adrenalectomy, radical prostatectomy, and cystectomy. With the increasing use of electrosurgical generators, the market segment for urology is expected to garner a substantial market share.

The rising cancer cases are also contributing to the segment's growth. For instance, as per the report published by the American Cancer Society in January 2022, an estimated 81,180 new cases of bladder cancer, with 61,700 in men and 19,480 in women, were registered in United States. This shows a high burden of the disease and increases the demand for the resection of the tumor. Cystectomy is a procedure in which the urinary bladder is removed surgically to treat bladder cancer.

Similarly, per the above source, prostate cancer is one of the most common cancers in American men. An estimated 268,490 new cases of prostate cancer were registered in 2022. Hence, the demand for cystectomy and prostatectomy using electrosurgical generators is expected to increase, which ultimately drives the market demand for generators in the urology segment.

Furthermore, in September 2021, Olympus launched its first devices in the new POWERSEAL family of advanced bipolar surgical energy products. The POWERSEAL devices can be used in numerous forms of surgical intervention, including urological surgical procedures. Hence with new product approvals and launches, the demand for electrosurgical generators is anticipated to observe significant growth over the forecast period.

North America Expected to Dominate the Market over the Forecast Period

The market for electrosurgical generators in North America is likely to be dominated by United States due to the region's sophisticated healthcare facilities and an advanced technology approach. The major factors, such as the increasing burden of chronic diseases like cancer and the growing geriatric population, along with technological advancements, are expected to fuel the market's growth.

For instance, the Canadian Cancer Society estimated 233,900 people in Canada to be diagnosed with cancer by the end of 2022, which is a high count compared to the 229,200 cases in 2021. The increase in cancer cases requires the resection of the tumors, which can be achieved using electrosurgical procedures and is thus expected to drive the market over the forecast period.

Furthermore, according to the Health Authorities in B.C. 2022, the surgical wait time for 90% of skin tumor removal cases in Canada is estimated at 15.2 weeks. Longer wait times for open surgeries will bolster the demand for minimally invasive surgeries such as electrosurgical procedures, boosting the demand for electrosurgical generators across healthcare facilities.

Moreover, the new product approvals and launches by the major market players are helping the market grow. For instance, in January 2022, Ethicon received United States FDA approval for the Megadyne Electrosurgical Generator. It is intended to be used as a general-purpose electrosurgical generator for a wide variety of open and laparoscopic procedures. Hence, the new approval of the electrosurgical generators in the region, in turn, increases the scope of the device towards multiple applications and helps the market to grow over the study period.

Competitive Landscape

The electrosurgical generator market is moderately fragmented. The global key players are manufacturing the majority of the electrosurgical generators. Market leaders who have greater resources for research and a better distribution network have carved out a place for themselves in the industry. Some of the major players include Medtronic, CONMED Corporation, Johnson & Johnson Services, Inc. (Ethicon, Inc.), Olympus Corporation, B. Braun SE, Aspen Surgical (Symmetry Surgical Inc.), Medrange Corporation, Applied Medical Resources Corporation, KARL STORZ SE & Co. KG, BD (Becton, Dickinson, and Company), and US Medical Innovations.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Chronic Diseases and Geriatric Population
    • 4.2.2 Increasing Demand for Minimally Invasive Surgeries
    • 4.2.3 Technological Advancements in Electrosurgical Units
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Electrosurgical Procedures
    • 4.3.2 Stringent Regulatory Frameworks
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Monopolar
    • 5.1.2 Bipolar
    • 5.1.3 Both
  • 5.2 By Application
    • 5.2.1 General Surgery
    • 5.2.2 Urology
    • 5.2.3 Neurology
    • 5.2.4 Gynecology
    • 5.2.5 Gastroenterology
    • 5.2.6 Other Applications (Cardiology, Plastic Surgery, and Dermatology)
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgery Centers
    • 5.3.3 Other End-users (Clinics, Trauma Centers, among others)
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic
    • 6.1.2 CONMED Corporation
    • 6.1.3 Johnson & Johnson Services, Inc. (Ethicon, Inc.)
    • 6.1.4 Olympus Corporation
    • 6.1.5 B. Braun SE
    • 6.1.6 Aspen Surgical (Symmetry Surgical Inc.)
    • 6.1.7 Medrange Corporation
    • 6.1.8 Applied Medical Resources Corporation
    • 6.1.9 KARL STORZ SE & Co. KG
    • 6.1.10 BD (Becton, Dickinson and Company)
    • 6.1.11 US Medical Innovations

7 MARKET OPPORTUNITIES AND FUTURE TRENDS